The OxVALVE population cohort study (OxVALVE-PCS) - Population screening for undiagnosed valvular heart disease in the elderly: Study design and objectives

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Coffey, Sean ^a   D'Arcy, Joanna L ^a   Loudon, Margaret A ^a   Mant, David ^b   Farmer, Andrew J ^b   Prendergast, Bernard D ^a  

^a NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION RESEARCH; PREVALENCE; QUALITY CONTROL; QUESTIONNAIRE; SCREENING; SELF EVALUATION; UNITED KINGDOM; VALVULAR HEART DISEASE; VITAL SIGN;

EID: 84984628307     PISSN: 2398595X     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2014-000043     Document Type: Article

References (31)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.
2. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
3. Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-56.
4. Chan KL, Teo K, Dumesnil JG, et al. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-14.
5. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
6. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
7. Taylor HA, Clark BL, Garrison RJ, et al. Relation of aortic valve sclerosis to risk of coronary heart disease in African-Americans. Am J Cardiol 2005;95:401-4.
8. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902.
9. Gardin JM, Wong ND, Bommer W, et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr 1992;5:63-72.
10. Devereux RB, Roman MJ, Paranicas M, et al. Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 1997;10:619-28.
11. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.
12. Office for National Statistics. 2011 census data for England and Wales on Nomis. http://www.nomisweb.co.uk/census/2011 (accessed 16 Jan 2014).
13. Campeau L. Letter: grading of angina pectoris. Circulation 1976;54:522-3.
14. Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7-11.
15. Andre F, Celik C, Abdel-Aty H, et al. Comparison of parameters for left ventricular volumes and function between echocardiography and cardiovascular magnetic resonance in a large group of cardiac patients. J Cardiovasc Magn Reson 2013;15:E74.
16. Gudmundsson P, Rydberg E, Winter R, et al. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol 2005;101:209-12.
17. Shahgaldi K, Gudmundsson P, Manouras A, et al. Visually estimated ejection fraction by two dimensional and triplane echocardiography is closely correlated with quantitative ejection fraction by real-time three dimensional echocardiography. Cardiovasc Ultrasound 2009;7:41.
18. Steeds R, Wharton G, Allen J, et al. Echocardiography: guidelines for valve quantification. http://www.bsecho.org.uk/education/postersguides/ (accessed 16 Jan 2014).
19. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
20. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
21. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-6.
22. Mant D, Fitzpatrick R, Hogg A, et al. Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Pract 1990;40:423-5.
23. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med 2001;33:337-43.
24. Dyer MTD, Goldsmith KA, Sharples LS, et al. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13.
25. Okrah K, Vaughan-Sarrazin M, Cram P. Trends in echocardiography utilization in the Veterans Administration Healthcare System. Am Heart J 2010;159:477-83.
26. National Institute for Health and Clinical Excellence. MI: secondary prevention. London: National Institute for Health and Clinical Excellence, 2007.
27. Aronow WS, Kronzon I. Prevalence and severity of valvular aortic stenosis determined by Doppler echocardiography and its association with echocardiographic and electrocardiographic left ventricular hypertrophy and physical signs of aortic stenosis in elderly patients. Am J Cardiol 1991;67:776-7.
28. Aronow WS, Ahn C, Kronzon I. Prevalence of echocardiographic findings in 554 men and in 1,243 women aged >60 years in a long-term health care facility. Am J Cardiol 1997;79:379-80.
29. Aronow WS, Ahn C, Shirani J, et al. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999;83:599-600.
30. Centers for Disease Control and Prevention. CDC Wonder. 2012. http://wonder.cdc.gov/ (accessed 16 Jan 2014).
31. d'Arcy JL, Prendergast BD, Chambers JB, et al. Valvular heart disease: the next cardiac epidemic. Heart 2011;97:91-3.